Picton Mahoney Asset Management’s Acceleron Pharma XLRN Stock Holding History

Picton Mahoney Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35,000	Closed	-$6.03M	–	1115
2021 Q3	$6.03M	Buy	+35,000	New	+$4.58M	0.22%	102

Picton Mahoney Asset Management's XLRN Position: Q4 2021 in Review

Picton Mahoney Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 35,000 shares — an estimated $6.03M sold.

Picton Mahoney Asset Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $6.03M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Picton Mahoney Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Picton Mahoney Asset Management sold 35,000 Acceleron Pharma shares in Q4 2021, an estimated $6.03M.
Picton Mahoney Asset Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Picton Mahoney Asset Management's Acceleron Pharma position peaked at $6.03M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.